参考文献/References:
[1]Sandall S,Fagerstrom C,Ferenz NP,et al.A Birl-Slil5 complex connects centromeres to microtubules and is required to sense kinetochore tension[J].Cell,2008,127(6):1179-1191.
[2]Gurpinar E,Grizzle WE,Piazza GA.NSAIDs inhibit tumorigenesis, but how?[J].Clin Cancer Res,2014,20(5):1104-1113.
[3]Sano H,Kawahito Y,Wilder RL,et al．Expression of cyclooxygenase-1 and-2 in human colorectal cancer[J]．Cancer Res,1995,55(17):3785-3789．
[4]Ferrai JG,Wallace JL,Mcknighe W,et al.Induction of cyclooxygenase-1 and 2 in the rat stomach during end toxemia:role in resistance to damage[J].Gastvoenterol,1997(113):195.
[5]刘宇飞,陈路,胡余昌,等．乳头状汗腺瘤9 例临床病理分析[J]．临床与实验病理学杂志,2010,26(2):215-219．
[6]Konopka TE，Barker JE,Bamford TL,et al．Nitdc oxide snthaseⅡgene disruption：Implicatjons for lumor growth and vascular endothelial growth production[J].Cancer Res,2001,61(7):3182-3187．
[7]Zech B,Kohl R,von Knethen A,et al.Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases[J].Biochem,2003,371（Pt3):1055-1064.
[8]Callejas NA,Fernandes-Martinez A,Castrillo A,et al.Selective inhibitors of cyclooxygenase-2 delay the activation of nuclear factor kappa B and attenuate the expression of inflammatory genes in murine macrophages treated with lipopolysaccharide[J].Mol Pharmacol,2003,63(3):671-677.
[9]Vermeulen L,Vanden Berghe W,Haegeman G.Regulation of NF-kappa B transcriptional activity[J].Cancer Treat Res,2006(130):89-102.
[10]Josbert JK,Johan AO,Paul D,et al.Molecular analysis of sulindac resisitant adenomas in familial adenomatous polyposis[J].Clin Cancer Res,2001(7):4000-4007.
[11]ENJ Boon,JJ Keller,TAM Wornhoudt,et al.Sulindac targets nuclear β-catenin accmulation and Wnt signaling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer lines[J].Br J Cancer,2004(90):224-229.
[12]周蕾,于东红,王萍,等.舒林酸对胃癌细胞株BGC-823作用的实验研究[J].蚌埠医学院学报,2007,32(2):132-135.
[13]费素娟,朱祖安,刘莹.尼美舒利、舒林酸对人胃癌SGC-7901细胞增殖及COX-2、iNOS表达的抑制作用[J].南京医科大学学报（自然科学版),2005,25(12):914-917.
[14]蔡红星,朱祖安,朱正秋.NF-кB途径在舒林酸促人胃癌SGC-7901细胞凋亡中的作用[J].徐州医学院学报,2009,29(12):856-859.
[15]吴志刚,马庆久,何显力,等.舒林酸对结肠癌细胞系SW480FasL蛋白表达及诱导淋巴细胞凋亡的影响[J].西安交通大学学报（医学版),2005,26(4):374-376.
[16]聂家艳,黄杰安,唐国都等.舒林酸对人结肠癌细胞凋亡及相关基因表达谱的作用[J].世界华人消化杂志,2008,16(25):2826-2830.
[17]耿礼文,赵韵春,梁桃.舒林酸抑制结肠癌细胞株增殖诱导凋亡[J].重庆医学,2008,37(15):1704-1708.
[18]吴小娟,刘雪,汤绍辉等.舒林酸对结肠癌细胞HT-29增殖和凋亡的影响[J].现代医院,2016,16(5):653-655.
[19]Tai WP, Hu PJ, Wu J,et al.The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac. Tumori,2014,100(1):97-101.
[20]刘军,牟艳玲,靳晶，等.舒林酸对人结肠癌细胞miRNA-17和miRNA-21表达抑制作用机制探讨[J].中华肿瘤防治杂志,2014,21(7):485-489.
[21]Li X,Pathi SS,Safe S.Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity proteintranscription factors[J].BMC Cancer,2015,16(15):974.
[22]Mladenova D,Pangon L,Currey N.Sulindac activates NF-κB signaling in colon cancer cells[J].Cell Commun Signal,2013,1(11):73.
[23]安燕芳,吕愈敏,叶嗣懋.舒林酸对家族性腺瘤性息肉病的疗效及作用机制的探讨[J].中华消化杂志,2000,20(4):243-245.
[24]李军,吕愈敏,顾芳.舒林酸治疗家族性腺瘤性息肉病患者结直肠腺瘤的长期疗效观察[J].肿瘤防治研究,2008,35(12):888-891.
[25]Kim KY,Jeon SW,Park JG,et al.Regression of Colonic Adenomas After Treatment With Sulindac in Familial Adenomatous Polyposis: A Case With a 2-Year Follow-up Without a Prophylactic Colectomy[J].Ann Coloproctol,2014,30(4):201-204.
[26]黄伟平,黄月红,陈治新,等.舒林酸对HBV X基因转染的肝癌细胞Wnt信号通路的影响[J].胃肠病学和肝病学杂志,2010,19(8):703-706.
[27]孙波,吴云林,王升年,等.舒林酸诱导人肝细胞凋亡及环氧合酶-2和Bcl-2蛋白表达的影响[J].中华消化杂志,2002,22(6):338-340.
[28]卞保祥,宋子琰,熊光苏.舒林酸对人胰腺癌细胞PANC-1增殖和凋亡的影响及机制探讨[J].中国生化药学杂志,2014,7(34):23-26.
[29]Murray OT,Wong CC,Vrankova K,et al.Phospho-sulindac inhibits pancreatic cancer growth:NFATc1 as a drug resistance candidate[J].Int J Oncol,2014,44(2):521-529.
[30]邵娟,辛晓燕,魏燕,等.舒林酸对卵巢细胞系CP70顺铂耐药性的逆转作用[J].现代肿瘤医学,2011,19(2):208-211.
[31]Zhang W,Pan YL．Ｒecombinant human endostatin combined with vinorelbine － cisplatin chemotherapy in treatment of human breast cancer xenograft in nude mice[J]．Chin J Mod Appl Pharm,2011(28):1085-1090．
[32]Rubin R．Researchers ponder aspirin＇s potential in preventing cancer[J]．JAMA,2014(312):1501-1502．
[33]周运江,王虎,随何欢,等.舒林酸硫化物对人乳腺癌细胞SKBR-3增殖与凋亡的影响[J].中国临床药理学杂志,2015,31(23):2325-2328.
[34]Takada Y,Bhardwaj A,Potdar P,et al.Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation,inhibition of expression of cyclooxygenase-2 and cyclin D1,and abrogation of tumor cell proliferation[J].Oncogene,2004,23(57):9247-9258.
[35]谢灵遐,胡丽娜,陈恒禧,等.NF-кB抑制物对顺铂诱导宫颈癌SiHa细胞凋亡的影响[J].四川大学学报(医学版),2013,44(1):36-41.
[36]Hsiu-Ni Kung,Tsai-Yun Weng,Yu-Lin Liu,et al.Sulindac Compounds Facilitate the Cytotoxicity of b-Lapachone by Up-Regulation of NAD(P)H QuinoneOxidoreductase in Human Lung Cancer Cells[J].PLoS One,2014,9(2):e88122.
[37]Cha BK,Kim YS,Hwang KE.Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymaltransition and suppress lung cancer migration and invasion via downregulation of sirtuin 1[J].Oncotarget,2016,7(35):57213-57227.